These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 35069580)

  • 1. Induction of Functional Specific Antibodies, IgG-Secreting Plasmablasts and Memory B Cells Following BCG Vaccination.
    Bitencourt J; Peralta-Álvarez MP; Wilkie M; Jacobs A; Wright D; Salman Almujri S; Li S; Harris SA; Smith SG; Elias SC; White AD; Satti I; Sharpe SS; O'Shea MK; McShane H; Tanner R
    Front Immunol; 2021; 12():798207. PubMed ID: 35069580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Humoral Immune Response to BCG Vaccination.
    Tanner R; Villarreal-Ramos B; Vordermeier HM; McShane H
    Front Immunol; 2019; 10():1317. PubMed ID: 31244856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prime-boost vaccination with Bacillus Calmette Guerin and a recombinant adenovirus co-expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis induces robust antigen-specific immune responses in mice.
    Li W; Li M; Deng G; Zhao L; Liu X; Wang Y
    Mol Med Rep; 2015 Aug; 12(2):3073-80. PubMed ID: 25962477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fusion protein Ag85B-MPT64(190-198)-Mtb8.4 has higher immunogenicity than Ag85B with capacity to boost BCG-primed immunity against Mycobacterium tuberculosis in mice.
    Luo Y; Wang B; Hu L; Yu H; Da Z; Jiang W; Song N; Qie Y; Wang H; Tang Z; Xian Q; Zhang Y; Zhu B
    Vaccine; 2009 Oct; 27(44):6179-85. PubMed ID: 19712772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative BCG delivery strategies improve protection against Mycobacterium tuberculosis in non-human primates: Protection associated with mycobacterial antigen-specific CD4 effector memory T-cell populations.
    Sharpe S; White A; Sarfas C; Sibley L; Gleeson F; McIntyre A; Basaraba R; Clark S; Hall G; Rayner E; Williams A; Marsh PD; Dennis M
    Tuberculosis (Edinb); 2016 Dec; 101():174-190. PubMed ID: 27865390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of mycobacterial protective immunity by sublingual BCG vaccination.
    Eickhoff CS; Blazevic A; Killoran EA; Morris MS; Hoft DF
    Vaccine; 2019 Aug; 37(36):5364-5370. PubMed ID: 31331776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Humoral Immunity to Mycobacterium tuberculosis-Specific Antigens for Correlation with Clinical Status and Effective Vaccine Development.
    Niki M; Suzukawa M; Akashi S; Nagai H; Ohta K; Inoue M; Niki M; Kaneko Y; Morimoto K; Kurashima A; Kitada S; Matsumoto S; Suzuki K; Hoshino Y
    J Immunol Res; 2015; 2015():527395. PubMed ID: 26568961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal Vaccination with Mannosylated Chitosan Formulated DNA Vaccine Enables Robust IgA and Cellular Response Induction in the Lungs of Mice and Improves Protection against Pulmonary Mycobacterial Challenge.
    Wu M; Zhao H; Li M; Yue Y; Xiong S; Xu W
    Front Cell Infect Microbiol; 2017; 7():445. PubMed ID: 29085809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robust IgM responses following intravenous vaccination with Bacille Calmette-Guérin associate with prevention of Mycobacterium tuberculosis infection in macaques.
    Irvine EB; O'Neil A; Darrah PA; Shin S; Choudhary A; Li W; Honnen W; Mehra S; Kaushal D; Gideon HP; Flynn JL; Roederer M; Seder RA; Pinter A; Fortune S; Alter G
    Nat Immunol; 2021 Dec; 22(12):1515-1523. PubMed ID: 34811542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ag85B-ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infection.
    van Dissel JT; Soonawala D; Joosten SA; Prins C; Arend SM; Bang P; Tingskov PN; Lingnau K; Nouta J; Hoff ST; Rosenkrands I; Kromann I; Ottenhoff TH; Doherty TM; Andersen P
    Vaccine; 2011 Mar; 29(11):2100-9. PubMed ID: 21256189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Human Antibodies to Arabinomannan With Enhanced Mycobacterial Opsonophagocytosis and Intracellular Growth Reduction.
    Chen T; Blanc C; Eder AZ; Prados-Rosales R; Souza AC; Kim RS; Glatman-Freedman A; Joe M; Bai Y; Lowary TL; Tanner R; Brennan MJ; Fletcher HA; McShane H; Casadevall A; Achkar JM
    J Infect Dis; 2016 Jul; 214(2):300-10. PubMed ID: 27056953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the Infant Immune System and the Influence and Immunogenicity of BCG Vaccination in Infant and Adult Rhesus Macaques.
    Sarfas C; White AD; Sibley L; Morrison AL; Gullick J; Lawrence S; Dennis MJ; Marsh PD; Fletcher HA; Sharpe SA
    Front Immunol; 2021; 12():754589. PubMed ID: 34707617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural and trained innate immunity against Mycobacterium tuberculosis.
    Ferluga J; Yasmin H; Al-Ahdal MN; Bhakta S; Kishore U
    Immunobiology; 2020 May; 225(3):151951. PubMed ID: 32423788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Divergent effect of bacillus Calmette-Guérin (BCG) vaccination on Mycobacterium tuberculosis infection in highly related macaque species: implications for primate models in tuberculosis vaccine research.
    Langermans JA; Andersen P; van Soolingen D; Vervenne RA; Frost PA; van der Laan T; van Pinxteren LA; van den Hombergh J; Kroon S; Peekel I; Florquin S; Thomas AW
    Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11497-502. PubMed ID: 11562492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Mycobacterium bovis BCG-naked DNA prime-boost vaccination strategy induced CD4⁺ and CD8⁺ T-cell response against Mycobacterium tuberculosis immunogens.
    Lu M; Xia ZY; Bao L
    J Immunol Res; 2014; 2014():395626. PubMed ID: 24741595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of individual-level factors on Ex vivo mycobacterial growth inhibition: Associations of immune cell phenotype, cytomegalovirus-specific response and sex with immunity following BCG vaccination in humans.
    Prabowo SA; Smith SG; Seifert K; Fletcher HA
    Tuberculosis (Edinb); 2019 Dec; 119():101876. PubMed ID: 31698310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune gene networks of mycobacterial vaccine-elicited cellular responses and immunity.
    Huang D; Qiu L; Wang R; Lai X; Du G; Seghal P; Shen Y; Shao L; Halliday L; Fortman J; Shen L; Letvin NL; Chen ZW
    J Infect Dis; 2007 Jan; 195(1):55-69. PubMed ID: 17152009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of innate and cell-mediated immunity by antimycobacterial antibodies.
    de Vallière S; Abate G; Blazevic A; Heuertz RM; Hoft DF
    Infect Immun; 2005 Oct; 73(10):6711-20. PubMed ID: 16177348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA vaccine with discontinuous T-cell epitope insertions into HSP65 scaffold as a potential means to improve immunogenicity of multi-epitope Mycobacterium tuberculosis vaccine.
    Wu M; Li M; Yue Y; Xu W
    Microbiol Immunol; 2016 Sep; 60(9):634-45. PubMed ID: 27531823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.